Lehman Brothers research : an analyst decides that the market overreacted to Merck's Vioxx woes /

In September 2004, Merck announced a voluntary withdrawal of Vioxx, one of its top earning drugs, after a new study suggested that it increased the risk of heart attacks. In only a few days, Merck's share price collapsed, and nearly $25 billion in shareholder wealth was erased. This case examin...

Full description

Bibliographic Details
Main Author:	Hutchins, Spencer (Author)
Corporate Author:	Sage Publications
Format:	eBook
Language:	English
Published:	[London] : SAGE, 2016.
Series:	SAGE knowledge. Cases.
Subjects:	Investment analysis > Case studies. Stocks > Prices > Case studies. Merck & Co. Electronic books.
Online Access:	Connect to the full text of this electronic book

Internet

Connect to the full text of this electronic book

Available Online

Holdings details from Available Online
Call Number	Status	Get It
Call Number:		HG4529

HG4529	Available